Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0N1HW
|
||||
Former ID |
DNC000859
|
||||
Drug Name |
L-745,870
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Psychotic disorders [ICD9: 290-299; ICD10:F20-F29] | Phase 2 | [540265] | ||
Structure |
Download2D MOL |
||||
Formula |
C18H19ClN4
|
||||
InChI |
InChI=1S/C18H19ClN4/c19-15-3-5-16(6-4-15)23-10-8-22(9-11-23)13-14-12-21-18-17(14)2-1-7-20-18/h1-7,12H,8-11,13H2,(H,20,21)
|
||||
InChIKey |
OGJGQVFWEPNYSB-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 158985-00-3
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
5007730, 7979687, 11056334, 11111360, 11113847, 14850833, 24263007, 26752020, 39340909, 47365384, 47736667, 47880157, 48110628, 48254023, 50070526, 50071164, 50104687, 50924052, 53787753, 57304374, 57359386, 84970653, 85209133, 85788363, 90340721, 103165750, 103947633, 114155529, 124750001, 124880510, 124880511, 124880512, 128805148, 134341004, 135275785, 135710076, 136351193, 136897518, 137035783, 143160225, 162222310, 164779492, 170485727, 178100340, 179293898, 203086700, 223259268, 227308076, 252432821
|
||||
Target and Pathway | |||||
Target(s) | D(4) dopamine receptor | Target Info | Antagonist | [535158], [536766] | |
References | |||||
Ref 535158 | Comparative molecular field analysis of dopamine D4 receptor antagonists including 3-[4-(4-chlorophenyl)piperazin-1-ylmethyl]pyrazolo[1,5-a]pyridine (FAUC 113), 3-[4-(4-chlorophenyl)piperazin-1-ylmethyl]-1H-pyrrolo-[2,3-b]pyridine (L-745,870), and clozapine. J Med Chem. 2001 Apr 12;44(8):1151-7. | ||||
Ref 536766 | Dopamine D4 receptor involvement in the discriminative stimulus effects in rats of LSD, but not the phenethylamine hallucinogen DOI. Psychopharmacology (Berl). 2009 Apr;203(2):265-77. Epub 2008 Jul 6. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.